Coen Stacy Ann
Related Filers (2)
Other (8)
144
Monday, 2/5/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 12/1/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 11/17/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 11/16/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 11/15/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/9/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 8/4/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/2/2023
Filing for proposed sale of securities under Rule 144
Ownership (20)
3
Tuesday, 2/13/2024
FibroBiologics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 2/12/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/6/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/5/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/3/2024
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/5/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/17/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/11/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/11/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/4/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/7/2023
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/27/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/5/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/8/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/4/2022
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/4/2020
ImmunoGen, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/4/2020
ImmunoGen, Inc.: Statement of changes in beneficial ownership of securities